annual cash & cash equivalents:
$84.38M-$72.64M(-46.26%)Summary
- As of today (June 19, 2025), IDYA annual cash & cash equivalents is $84.38 million, with the most recent change of -$72.64 million (-46.26%) on December 31, 2024.
- During the last 3 years, IDYA annual cash & cash equivalents has fallen by -$7.67 million (-8.33%).
- IDYA annual cash & cash equivalents is now -46.26% below its all-time high of $157.02 million, reached on December 31, 2023.
Performance
IDYA Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$130.00M+$45.62M(+54.06%)Summary
- As of today (June 19, 2025), IDYA quarterly cash & cash equivalents is $130.00 million, with the most recent change of +$45.62 million (+54.06%) on March 31, 2025.
- Over the past year, IDYA quarterly cash & cash equivalents has increased by +$21.65 million (+19.98%).
- IDYA quarterly cash & cash equivalents is now -67.52% below its all-time high of $400.28 million, reached on September 30, 2024.
Performance
IDYA quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
IDYA Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -46.3% | +20.0% |
| 3 y3 years | -8.3% | +135.1% |
| 5 y5 years | +147.7% | +266.6% |
IDYA Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -46.3% | +22.9% | -67.5% | +164.7% |
| 5 y | 5-year | -46.3% | +147.7% | -67.5% | +266.6% |
| alltime | all time | -46.3% | +1315.5% | -67.5% | +534.0% |
IDYA Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $130.00M(+54.1%) |
| Dec 2024 | $84.38M(-46.3%) | $84.38M(-78.9%) |
| Sep 2024 | - | $400.28M(+118.7%) |
| Jun 2024 | - | $183.05M(+69.0%) |
| Mar 2024 | - | $108.34M(-31.0%) |
| Dec 2023 | $157.02M(+128.8%) | $157.02M(+3.4%) |
| Sep 2023 | - | $151.85M(+47.7%) |
| Jun 2023 | - | $102.84M(+53.0%) |
| Mar 2023 | - | $67.24M(-2.0%) |
| Dec 2022 | $68.63M(-25.4%) | $68.63M(-32.7%) |
| Sep 2022 | - | $101.95M(+107.6%) |
| Jun 2022 | - | $49.11M(-11.2%) |
| Mar 2022 | - | $55.29M(-39.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $92.05M(+27.8%) | $92.05M(-15.1%) |
| Sep 2021 | - | $108.43M(+19.9%) |
| Jun 2021 | - | $90.43M(-33.9%) |
| Mar 2021 | - | $136.75M(+89.8%) |
| Dec 2020 | $72.04M(+111.5%) | $72.04M(-11.3%) |
| Sep 2020 | - | $81.24M(-44.9%) |
| Jun 2020 | - | $147.54M(+316.1%) |
| Mar 2020 | - | $35.46M(+4.1%) |
| Dec 2019 | $34.07M(+66.1%) | $34.07M(-12.3%) |
| Sep 2019 | - | $38.85M(-55.9%) |
| Jun 2019 | - | $88.11M(+149.6%) |
| Mar 2019 | - | $35.30M(+72.2%) |
| Dec 2018 | $20.50M(+244.0%) | $20.50M |
| Dec 2017 | $5.96M | - |
FAQ
- What is IDEAYA Biosciences annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for IDEAYA Biosciences?
- What is IDEAYA Biosciences annual cash & cash equivalents year-on-year change?
- What is IDEAYA Biosciences quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for IDEAYA Biosciences?
- What is IDEAYA Biosciences quarterly cash & cash equivalents year-on-year change?
What is IDEAYA Biosciences annual cash & cash equivalents?
The current annual cash & cash equivalents of IDYA is $84.38M
What is the all time high annual cash & cash equivalents for IDEAYA Biosciences?
IDEAYA Biosciences all-time high annual cash & cash equivalents is $157.02M
What is IDEAYA Biosciences annual cash & cash equivalents year-on-year change?
Over the past year, IDYA annual cash & cash equivalents has changed by -$72.64M (-46.26%)
What is IDEAYA Biosciences quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of IDYA is $130.00M
What is the all time high quarterly cash & cash equivalents for IDEAYA Biosciences?
IDEAYA Biosciences all-time high quarterly cash & cash equivalents is $400.28M
What is IDEAYA Biosciences quarterly cash & cash equivalents year-on-year change?
Over the past year, IDYA quarterly cash & cash equivalents has changed by +$21.65M (+19.98%)